AEterna Zentaris Inc (NASDAQ:AEZS)
| 2.10 Data as of May 17 |  +0.04 / +1.94%Today’s Change | 1.70 Today|||52-Week Range 5.63 | -11.76% Year-to-Date |
Latest AEZS News | Press Releases
| Disappointing 1Q Earnings for IART - Analyst Blog May 10 / Zacks.com |
Today’s Trading
| Previous close | 2.06 |
| Today’s open | 2.09 |
| Day’s range | 2.06 - 2.15 |
| Volume | 224,282 |
| Average volume (3 months) | 342,896 |
| Market cap | $53.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +40.80% |
| Earnings growth (this year) | +38.96% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -6.62% |
| P/E ratio | -- |
| Price/Sales | 1.40 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRLRFCrailar Technologies... | -0.02 | -1.67% |
| ENMDEntreMed Inc | -0.02 | -1.07% |
| MAXYMaxygen Inc | +0.02 | +0.85% |
| ARWRArrowhead Research C... | +0.12 | +5.48% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $33.7M |
| Annual profit (last year) | -$20.4M |
| Net profit margin | -60.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jürgen Engel, PhD |
Chief Financial Officer & Senior Vice President Dennis Turpin |
Corporate headquarters Québec, Québec |
Forecasts
